Maple Leaf Research CRS

Site Details

LOCATION

14 College St.

Suite 403

Toronto, Ontario. M5G 1K2

Get Directions

SiteType

CRS

CRS Coordinator

Roberta Halpenny

rhalpenny@mlmedical.com

416-465-7936

CRS Leader

Graham Smith

gsmith@mlmedical.com

416-456-7936

Site Trials

HIV comorbidities and complications

Closed to accrual

A5332: REPRIEVE Trial

In this study, people between the ages of 40 and 75 with HIV will be randomized (like flipping a coin) to take the pill pitavastatin OR a placebo (non-active pill) to see if pitavastatin can help prevent heart disease and death in people who are taking HIV medication. You will not know if you are taking pitavastatin or placebo. The REPRIEVE trial will enroll about 7500 people from several countries.